Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

10x Genomics, Inc. (TXG)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-K10-K
Revenue  490.5298.8245.9146.371.1
            Revenue growth  64.1%21.5%68.1%105.8% 
Cost of revenue  74.158.561.028.710.6
    Gross profit  416.4240.4184.9117.760.5
            Gross margin  84.9%80.4%75.2%80.4%85.1%
   
Operating expenses:       
Research and development  211.8123.483.147.532.2
Selling, general and administrative  257.6202.3130.887.946.7
    Total operating expenses  938.0774.5215.4228.478.9
    Loss from operations  -52.3-534.1-30.6-110.8-18.4
            Operating margin  -10.7%-178.7%-12.4%-75.7%-25.8%
   
Other income (expense):       
Interest income  0.21.52.81.00.3
Interest expense  -0.9-1.7-3.1-2.4-0.8
Other expense, net  -0.81.3-0.2-0.20.1
    Total other income  -1.51.0-0.5-1.6-0.4
    Loss before provision for income taxes  -53.7-534.5-31.0-112.4-18.7
Provision for income taxes  4.58.30.20.10.0
    Net loss  -58.2-542.7-31.3-112.5-18.8
   
Net loss per share, basic (in dollars per share)  ($0.53)($5.37)($0.80)($8.40)($1.62)
Net loss per share, diluted (in dollars per share)  ($0.53)($5.37)($0.80)($8.40)($1.62)
   
Weighted-average shares of common stock used in computing net loss per share, basic  110.3101.239.113.411.6
Weighted-average shares of common stock used in computing net loss per share, diluted  110.3101.239.1  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy